Press Releases

Nov 02, 2016

Veracyte Announces Pricing of Public Offering of 5,000,000 Shares of Common Stock

Read More

Nov 01, 2016

Veracyte Announces Proposed Public Offering of Common Stock

Read More

Oct 26, 2016

New Data Show that Use of Percepta® Bronchial Genomic Classifier Reduces Surgeries and Other Costly Procedures in Lung Cancer Screening and Diagnosis

Read More

Oct 25, 2016

Veracyte Announces Launch of Envisia™ Genomic Classifier for Improved Diagnosis of Idiopathic Pulmonary Fibrosis at CHEST Annual Meeting 2016

Read More

Oct 17, 2016

Veracyte Releases Preliminary Third Quarter 2016 Financial Results

Read More

Oct 13, 2016

Data Demonstrating Clinical Value of Veracyte Genomic Tests for Use in Lung Cancer and IPF to Be Presented at CHEST Annual Meeting 2016

Read More

Sep 30, 2016

Veracyte Releases Statement on CMS's Final 2017 Gapfill Rate for the Afirma® Gene Expression Classifier

Read More

Sep 23, 2016

Veracyte Presents Data Demonstrating Potential to Enhance Afirma® Gene Expression Classifier Using an RNA Sequencing Platform

Read More

Sep 15, 2016

Veracyte Secures Draft Medicare Local Coverage Determination for Percepta® Bronchial Genomic Classifier from Palmetto GBA

Read More

Sep 15, 2016

Veracyte Announces Data from Seven Afirma® Gene Expression Classifier Studies to Be Presented at the 86th Annual Meeting of the American Thyroid Association

Read More